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Abstract
Background: Alternate day calorie restriction (CR) has been shown to be almost as beneficial as daily CR. The question arises
whether this concept is also applicable to alternating dietary composition.
Objective: To seek evidence that alternating high cholesterol (HC) - cholesterol-free (CON) Western diet can effectively
diminish hepatic and renal inflammation and cardiovascular risk factors as compared with daily HC-supplemented Western
diet.
Design: Four groups of ApoE*3Leiden mice, a humanized model for atherosclerosis, were subjected to different feeding
treatments for 16 weeks. Mice were fed CON diet; CON diet with 1% w/w cholesterol (HC); alternate (ALT) diet regimen of
CON (4 days) and HC (3 days); or CON diet supplemented with 0.43% (w/w) cholesterol (MC), with overall dietary cholesterol
intake equal to ALT. Plasma was analyzed for cardiovascular risk factors, aorta for atherosclerotic lesion formation, and liver
and kidney for inflammation.
Results: ALT diet but not MC was almost as effective as daily CON feeding in preventing disease development. Compared to
HC, the ALT group showed 62% lower hepatic nuclear factor kappa B (NF-kB) activity (P,0.001), a reduction of the
circulating inflammatory markers E-selectin (220%; P,0.05), vascular cell adhesion molecule 1 (VCAM-1; 215%; P,0.05)
and Serum Amyloid A (SAA; 231%; P,0.05), smaller atherosclerotic lesion sizes (251%; 46497610791 mm
2 vs.
94664616470 mm
2;P ,0.05) and diminished renal expression of specific inflammation and activation markers (VCAM-1,
227%; P,0.05; monocyte chemotactic protein-1 (MCP-1); 237%; P,0.01).
Conclusion: Alternate HC-CON feeding reproduced most of the beneficial effects of daily cholesterol-free diet, including
strongly diminished hepatic, vascular and renal activation and inflammation; also atherosclerosis was reduced by half as
compared to HC, albeit still higher compared to the CON group.
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Introduction
Cardiovascular disease (CVD) is the leading cause of morbidity
and mortality in industrialized countries. A better understanding of
modifiable risk factors for CVD is critical in order to effectively
prevent or retard this disease. Among the modifiable risk factors are
unhealthy diet and excessive calorie intake. It is well known that
improvements in dietary composition can strongly influence the risk
of developing CVD [1]. Similarly, caloric restriction reduces
metabolic risk factors for CVD [2;3]. However, compliance with
these broad guidelines is problematical and not acceptable to most
people despite the undisputed beneficial health outcomes. Therefore,
novel approaches for dietary interventions should be considered.
It may be more feasible in practice to introduce a form of
alternating dietary manipulation than daily dietary changes. In this
case dietary changes could be instituted for limited time periods.
Intuitively it seems likely that persons will find it easier to adapt to
this than to restrict their intake every day. Recent findings in
humans suggest that alternate-day fasting may indeed be a viable
diet option to help obese individuals lose weight and decrease
CVD [4]. Here we wish to seek evidence that alternate dietary
composition will also beneficially affect metabolic health. To this
end, we evaluated the effect of alternating high cholesterol (HC)
diet and cholesterol-free control (CON) diet on liver health and
macro- and microvascular function in a humanized mouse model
of CVD, the ApoE*3Leiden (ApoE3L) mouse [5].
We previously showed that feeding ApoE3L mice a Western
diet supplemented with HC (1% w/w), but not CON diet, induces
CVD risk factors such as hypercholesterolemia, systemic inflam-
mation and endothelial dysfunction, which precede atherosclerotic
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response was shown to be related to liver inflammation. Here we
wish to explore whether in a similar experimental set-up an
alternate HC diet (3 days) - CON diet (4 days) could diminish
hepatic inflammation and CVD risk factors and thereby decrease
atherosclerotic lesion formation as compared to continuous HC
feeding. To evaluate whether an alternate diet regimen may also
be beneficial for the microvasculature, we extended our analyses to
the kidney. The alternate diet regimen was also compared to
feeding mice daily 0.43% w/w cholesterol (MC), whereby the
overall cholesterol intake of the MC group equals that of the
alternate group. Our findings indicate that the principle of
alternate feeding regimens effectively diminishes metabolic and
vascular risk factors and improves the hepatic, renal, and vascular
health status in ApoE3L mice.
Methods
Ethics statement
The experiment was approved by and is in compliance with the
regulations set forward by the Ethical Committee on Animal Care
and Experimentation (Zeist, The Netherlands), approval number
DEC2688.
Animals
Sixty female ApoE*3Leiden mice (12–14 weeks old) were group
housed (3–5 mice per cage) with a 12 h light-dark cycle (7 a.m.–7
p.m. lights on). The mice had free access to food and water and
remained onmaintenancechow (SniffR/MdietV1530,Uden,The
Netherlands); composition specified in [7]) until the start of the
study. At T=0, the start of the study, the mice were divided into
four groups matched for plasma cholesterol and experimental diet
treatment was started. The first group (control group; ‘‘CON’’)
received an established [8] cholesterol-free Western type diet (CON
diet; rodent diet T, Hope Farms, Woerden, The Netherlands). The
second group was fed the same diet as CON but supplemented with
a high dose (1.0% w/w) of cholesterol (high cholesterol group;
‘‘HC’’). The third group was subject to alternate diet feeding, i.e. 3
days feeding of HC diet followed by 4 days of cholesterol-free CON
diet (alternating cholesterol group; ‘‘ALT’’). The fourth group was
treated with the same diet as CON but supplemented with 0.43%
w/w of cholesterol (medium cholesterol group; ‘‘MC’’) to achieve
the same dietary cholesterol intake as with ALT. The dietary
regimens are illustrated in Figure S1. Body weight (individually) and
food intake (at cage level) were monitored over time and blood
samples were taken by tail incision after 4 h of fasting (9 a.m. – 1
p.m.) at T=0 and on day 24, 52, 80 and 108, i.e. always at the end
ofa 3-daysHCfeedingperiodintheALTgroup.Tofurtheranalyze
theeffect ofalternatecholesterolfeedingonpredicted fluctuations of
plasma cholesterol, additional plasma was collected in the ALT
group at T=28, 56, 84 and 112 days (i.e. the last day of the CON
feeding periods) and at T=31, 59, 87, 115 days (i.e. the last day of
the HC feeding periods) (Figure S1). After sixteen weeks of
experimental diet feeding, the mice were sacrificed by CO2 and
organs were isolated and weighed. Hearts and kidneys (sinistra) were
fixed and embedded in paraffin; livers and kidneys (dextra) were snap
frozen in liquid N2 and stored at 280uC until further use.
Plasma analyses
Total plasma cholesterol and triglyceride levels were measured
using kits No. 11489437 and 11488872 (Roche Diagnostics,
Almere, The Netherlands), respectively, and the plasma levels of
soluble vascular cell adhesion molecule 1 (sVCAM-1; R&D
Systems), E-selectin (R&D Systems) and Serum Amyloid A
(SAA; Biosource) were determined by ELISA [9].
Liver inflammation
Nuclear factor kappa B (NF-kB) activity in liver was determined
as described [10], using TransAM transcription factor assay kit
no. 40097 (Active Motif Europe, Rixensart, Belgium). Briefly, liver
homogenates were prepared using the Nuclear Extract Kit
(no. 40010, Active Motif, Rixensart, Belgium). Equal amounts of
protein (6 mg/well) of the liver homogenates were used to
determine the amount of active p65-NF-kB.
Free cholesterol and cholesterol ester in liver
To determine intrahepatic cholesterol concentrations, liver samples
were homogenized. Cholesteryl acetate (2 mg) was added to each
sample as an internal standard. Lipids were extracted according to the
‘Bligh and Dyer method’ and neutral lipids were separated by high
performance thin layer chromatography on silica-gel-60 pre-coated
plates. Quantification of the lipid amounts was performed by scanning
the plates with a Hewlett Packard Scanjet 4500c and by integrating
the density areas with Tina version 2.09 software.
Atherosclerotic lesion analysis
Serial cross sections (5 mm-thick) were taken throughout the
entire aortic root area for histological analysis of atherosclerosis as
described [11]. Briefly, paraffin-embedded aortic cross-sections
were stained with hematoxylin-phloxine-saffron and atheroscle-
rotic lesion area was analyzed blindly in 4 cross-sections of each
specimen (at intervals of 50 mm). Cell-D software (Olympus Soft
Imagine Solutions GmbH) was used for morphometric computer-
assisted quantification of lesion number, lesion area and lesion
severity according to the classification of the American Heart
Association as established [12]. MAC-3 (BD-Pharmingen, cat#
550292) antibody was used to determine macrophage content.
MAC-3 positive staining of the atherosclerotic lesions was
quantified using Cell-D software (Olympus Soft Imagine Solutions
GmbH). CON mice hardly developed atherosclerotic lesions
(0.160.1 lesions per cross-section) and were therefore not included
in further statistical atherosclerosis analysis.
Renal RNA extraction and gene expression analysis
Total RNA was extracted from thirty 5- mm thin cryo-sections
from kidney using RNeasy Mini Plus Kit (Qiagen, Westburg,
Leusden, The Netherlands) according to the manufacturer’s
instructions. Integrity of RNA was determined by Agarose gel
electrophoresis. RNA quantity (OD-260) and quality (OD-260/
OD-280) were determined using a ND-1,000 UV-Vis spectropho-
tometer (NanoDrop Technologies, Rockland, DE).
Total RNA was reverse-transcribed using SuperScript III reverse
transcriptase (Invitrogen, Breda, The Netherlands) and random
hexamer primers (Promega, Leiden, The Netherlands). To detect
the expression of selected target genes Assays-On-Demand
TM gene
expression primer/probe sets (ABI Systems, Foster City, CA) were
used. Endogenous PPIA (assay ID Mm02342430_g1) was used as a
housekeeping gene along with the following probes: CD68 (assay
IDMm00839636_g1), monocyte chemotactic protein-1 (MCP-1;
assay IDMm00441242_m1), VCAM-1 (assay IDMm00449197
_m1), inter-cellular adhesion molecule 1 (ICAM-1; assay
IDMm00516023_m1, P-selectin (assay ID Mm00441295_m1), and
E-selectin (assay IDMm00441278_m1). Real-time PCR was per-
formed in duplicate and the obtained threshold cycle (CT) values
were averaged. Relative mRNA levels were calculated as 2
-DCT,i n
which DCT is CTgene of interest –C T PPIA.
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For light microscopy, 3 mM paraffin sections were stained with
Periodic acid-Schiff’s (PAS). In short, paraffin sections were
deparaffinized and re-hydrated to distilled water. Sections were
placed in 0.5% periodic acid solution for 5 minutes. After rinsing
in distilled water, sections were incubated in Schiff reagent (Sigma)
for 15 minutes, followed by rinsing in lukewarm water for 5
minutes. Sections were counterstained with Mayer’s hematoxylin
for 1 minute and washed in tap water. Immunohistochemical
staining for macrophages and VCAM-1 was performed on
acetone-fixed 5 mm cryosections using an anti-rabbit peroxidase-
based EnvisionH+ system (DakoCytomation, Carpinteria, CA,
USA). Briefly, sections were incubated for 60 min with rat-anti-
mouse CD68 (clone FA11, hybridoma supernatant), VCAM-1
(clone M/K-2.7, hybridoma supernatant) or isotype control
antibody (IgG2a, clone OX35, hybridoma supernatant) followed
by a 30 min incubation with 10 mg/ml unlabeled rabbit-anti-rat
secondary antibody (Vector Laboratories, Burlingame, CA, USA).
After detection of peroxidase activity with 3-amino-9-ethylcarba-
zole, sections were counterstained with Mayer’s hematoxylin.
Images were taken with a Leica microscope using QwinV3
software, and the extent of macrophage infiltration was deter-
mined by morphometry in a blinded manner using Leica Qwin V3
quips (Qwin V3 software, Leica Microsystems Imaging Solutions,
Ltd., Cambridge, UK) and expressed as percentage of positive
area.
Statistical analysis
Data were analyzed with SPSS 17.0 for Windows. Changes over
time were measured with repeated measures ANOVA with factors
treatment and time followed by least significant difference (LSD)
post-hoc analysis. Differences between groups at one specific time
point were analyzed with 1-way ANOVA followed by LSD post-
hoc analysis. Data that were not normally distributed were
analyzed with a non-parametric Mann-Whitney U test or a
Kruskal-Wallis test followed by a Dunn’s test. P,0.05 was
considered significant. Results are shown as mean 6 SEM.
Results
Alternate dietary regimen improves plasma lipids
Body weight and average food intake did not differ significantly
between the groups (Table 1). Starting baseline cholesterol levels at
T=0 were comparable between the groups (2.860.1 mM)
(Figure 1A). Feeding of a cholesterol-free Western type diet
(CON group) resulted in a moderate increase in plasma cholesterol
averaging 7.062.0 mM. A more pronounced increase in plasma
cholesterol was seen with high dose (1% w/w) cholesterol feeding
(HC group): after 24 days, plasma cholesterol levels had reached
17.360.6 mM, and stabilized at this level for the remainder of the
treatment period (average cholesterol 19.460.7 mM). Plasma
cholesterol in the ALT group fluctuated parallel to the alternate
HC diet-Con diet; after periods of HC diet, the plasma cholesterol
levels were comparable to those in the HC group, but levels
dropped rapidly to on average 11.960.9 mM after periods of
CON diet, pointing to a rapid adaptation to dietary cholesterol
intake. Plasma cholesterol levels in the medium dose (0.43% w/w)
cholesterol (MC) group stabilized at 18.060.8 mM, slightly lower
than those in the HC group.
Plasma triglycerides did not differ between the groups and
remained stable at 2.3 mM during the experimental period (data
not shown).
Alternate dietary regimen improves vascular and
systemic inflammation
Plasma levels of the vascular inflammation marker E-selectin
were on average 60.361.6 ng/mL at T=0 (Figure 1B). Levels in
the CON group slightly increased during the study, reaching
78.263.5 ng/mL at the end. HC feeding caused a more
pronounced and significant (P,0.05) increase in E-selectin with
endpoint levels of 96.366.7 ng/mL. Notably, alternate diet
feeding resulted in E-selectin levels comparable to those of the
CON group (74.462.4 ng/mL), and significantly lower than the
E-selectin levels in the HC group (P,0.01) on days 24, 80 and
108. The MC group showed E-selectin levels slightly, but
significantly higher than those in the ALT and CON groups,
but lower than in the HC group. For example, on day 24, E-
selectin level was 78.562.6 ng/mL in MC which was significantly
higher than the corresponding values in the ALT (70.362.2 ng/
mL; P,0.05) and CON (71.962.1 ng/mL; P,0.05) groups.
Plasma levels of another vascular inflammation marker,
VCAM-1, showed a similar response to the differing feeding
regimens as seen for E-selectin (Figure 1C). Levels in the CON
group increased from on average 1.3860.05 mg/mL at T=0 to
1.9960.06 mg/mL at the end of the experimental period. HC diet
feeding showed a significantly stronger increase in VCAM-1 levels
over time, reaching an average endpoint value of 2.4160.15 mg/
mL. Similarly as seen with E-selectin, VCAM-1 levels of the ALT
group did not significantly differ from the CON group (endpoint
value 2.0460.11 mg/mL; P=0.06 compared to HC), while the
MC group showed VCAM-1 levels in between the CON/ALT
groups and the HC group (endpoint value for MC: 2.1660.07 mg/
mL.
Figure 1D shows the effects of the different diets on the plasma
levels of the systemic inflammation marker, Serum Amyloid A
(SAA). At T=0, average plasma SAA levels were 7.462.5 mg/mL
Table 1. Characteristics of the four treatment groups at the end of the study.
CON (n=15) HC (n=13) ALT (n=13) MC (n=14)
Body weight (g) 22.860.5 23.760.4 22.660.4 23.860.5
Food intake (g/day) 2.4560.04 2.5160.07 2.2660.07 2.2960.03
Liver weight (g) 1.1260.05
a 1.5160.06
b 1.1160.03
a 1.3060.04
c
Intrahepatic cholesterolester (CE) (mg/mg protein) 15.660.9
a 32.260.8
b 28.060.6
c 29.96.07
c
Intrahepatic triglycerides (mg/mg protein) 62.965.5 76.963.5 69.062.5 68.764.1
Groups are abbreviated as: control mice fed a cholesterol-free Western type diet (CON); mice fed the same Western type diet but supplemented with high dose (1% w/
w) cholesterol (HC); mice with alternate CON (4 days) and HC (3 days) diet regimen (ALT); mice fed Western type diet supplemented with a medium dose (0.43% w/w)
cholesterol (MC). Data are expressed as means 6 SEM. Values in the same row with different superscript letters are significantly different. P,0.05.
doi:10.1371/journal.pone.0018432.t001
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8.064.5 mg/mL). Upon HC feeding, plasma SAA levels increased
gradually, eventually reaching 12.762.7 mg/mL (P,0.01). Again,
the alternate diet did not enhance plasma levels (8.462.6 mg/mL
at the end of the study) and plasma SAA values in the ALT group
were very comparable to those in the CON group. Endpoint SAA
levels in the MC group (9.963.1 mg/mL) were in between the
CON/ALT groups and the HC group.
Alternate dietary regimen reduces liver inflammation
Since SAA is a liver-derived inflammation marker the
expression of which is under control of the inflammatory
transcription factor NF-kB, we next compared hepatic NF-kB
activity between the groups using liver homogenates prepared at
sacrifice. HC feeding was associated with a marked 4-fold
(P,0.05) increase in hepatic NF-kB activity (Figure 2A) relative
to CON. In contrast, alternating cholesterol feeding hardly
affected NF-kB activity and the ALT group displayed a
comparable activity as the CON group. A considerable 3-fold
(P,0.05) elevation in NF-kB activity was seen with MC. Together,
this demonstrates that chronic dietary cholesterol exposure clearly
is adverse to the liver and that alternating cholesterol feeding is a
suitable way to prevent such effects.
We next analyzed the hepatic concentration of free cholesterol
(FC), which is a critical determinant of liver inflammation [13].
Indeed, FC concentrations were significantly higher in the HC
(14.760.3 mg/mg protein) and MC (14.060.3 mg/mg protein)
groups as compared to the CON group (11.560.4 mg/mg
protein; P,0.001) or the ALT group (12.960.3 mg/mg protein;
P,0.001) (Figure 2B). Similar differences between the groups
were found for the concentration of hepatic cholesterol ester (CE)
(Table 1). Consistent with the plasma triglyceride data, hepatic
triglyceride concentrations were comparable between the groups
(Table 1).
Alternate dietary regimen improves macrovascular
function in aorta
Atherosclerosis was analyzed after 16 weeks of experimental
diet treatment in the aortic valve area of the heart (see Figure S2
for representative photomicrographs). HC feeding and MC
feeding resulted in substantial atherosclerosis with total lesion
areas of 94664616470 mm
2 and 7867068877 mm
2 per cross
section, respectively (Figure 3A). The total lesion area of the
ALT group (46497610791 mm2 per cross section) was consid-
erably smaller than that of the HC group (251%; P,0.05) and
the MC group (241%; P,0.05), but still larger than that of the
Figure 1. Effect of alternate diet regimen on plasma lipids and inflammation markers. Plasma parameters over time for each treatment
group. A) Plasma cholesterol over time, B) plasma E-selectin, C) plasma VCAM-1, D) plasma serum amyloid A (SAA). Groups are abbreviated as: control
mice fed a cholesterol-free Western type diet (CON, n=15); mice fed the same Western type diet but supplemented with high dose (1% w/w)
cholesterol (HC, n=13); mice with alternate CON (4 days) and HC (3 days) diet regimen (ALT, n=13); mice fed Western type diet supplemented with a
medium dose (0.43% w/w) cholesterol (MC, n=14). * P,0.05 compared to CON, # P,0.05 compared to ALT, and P,0.05 compared to MC. Values
are presented as means 6 SEM.
doi:10.1371/journal.pone.0018432.g001
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2). The number of lesions in the
ALT and MC groups did not significantly differ from the HC
group (on average 3.460.3 lesions per cross section; data not
shown). Notably, the number of aortic segments free of lesions
were significantly higher in the ALT group (0.9660.30) than in
HC (0.2760.06; P,0.05) and MC (0.1160.05; P,0.01)
(Figure 3B).
Alternate dietary regimen reduces macrophage content
of aortic lesions
While CON livers hardly showed MAC-3 immunoreactivity
(IR; Figure 3C), HC treated animals showed pronounced staining
with a macrophage-positive area of 2275365555 mm
2. Alternate
dietary regimen significantly reduced the macrophage-positive IR
(844262115 mm
2;P ,0.05) relative to HC. MC treatment
reduced the macrophage to a lesser and insignificant extent
(1434163124 mm
2).
Together, the data indicate that alternate cholesterol feeding as
compared to continuous cholesterol feeding is beneficial for aortic
(macrovascular) function.
To assess whether the microvasculature would also benefit
from an alternate dietary regimen, we next analyzed kidney
integrity.
Alternate dietary regimen reduces renal inflammation
Renal mRNA expression levels of various genes related to
endothelial activation (VCAM-1, ICAM-1, E-selectin, P-selectin)
and inflammation (MCP-1, CD68) were significantly upregulated
with HC feeding compared to CON. Strikingly, in the ALT group,
these effects were either less pronounced (E-selectin, CD68) or
even absent (VCAM-1, ICAM-1, P-selectin, MCP-1) (Table 2).
Figure 2. Effect of alternate diet regimen on NFkB activity and
intrahepatic lipids. A) Active p65-NFkB expression in liver homog-
enates relative to CON, B) Intrahepatic free cholesterol concentrations.
Control mice fed a cholesterol-free Western type diet (CON, n=15);
high dose (1% w/w) cholesterol diet (HC, n=13); alternate CON (4 days)
and HC (3 days) diet regimen (ALT, n=13); medium dose (0.43% w/w)
cholesterol diet (MC, n=14). Values are presented as means 6 SEM.
*P ,0.05, ** P,0.01, *** P,0.001.
doi:10.1371/journal.pone.0018432.g002
Figure 3. Effect of alternate diet regimen on macrovascular
atherosclerotic disease. A) Total atherosclerotic lesion area per cross-
section, B) Lesion-free aortic segments per cross section, C) Macrophage
immunostaining (MAC-3 immunoreactivity). Control mice fed a cholester-
ol-free Western type diet (CON, n=14); high dose (1% w/w) cholesterol
diet (HC, n=12); alternateCON (4days) and HC (3 days) diet regimen (ALT,
n=12); medium dose (0.43% w/w) cholesterol diet (MC, n=12). Values are
presented as means 6 SEM.* P,0.05, ** P,0.01, *** P,0.001.
doi:10.1371/journal.pone.0018432.g003
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1 and E-selectin (moderate) but a strong upregulating effect
(comparable to HC) on P-selectin, MCP-1, CD68.
Consistent with these gene expression findings, immunohisto-
chemical analysis revealed an increased VCAM-1 immunoreac-
tivity (IR) in glomeruli of HC treated mice relative to CON mice
which showed hardly any IR. Under ALT diet conditions,
glomerular VCAM-1 expression was not stimulated and remained
comparably low as in CON. By contrast, chronic cholesterol
exposure in the MC group was again associated with elevated
VCAM-1 IR (Figure 4).
Compared to CON animals, mice fed HC or MC showed
significantly increased numbers of macrophages in glomeruli and
tubulo-interstitium (Figure 5A) as quantified by morphometry
(Figure 5B). Kidneys from ALT mice did not display any
macrophage accumulation and were indistinguishable from
CON mice.
To determine whether HC feeding would affect renal function,
we measured urinary albumin and creatinine levels in spot urine
samples. In all groups, urinary albumin/creatinine ratios were
similar (data not shown) and within the normal range suggesting
that the experimental diets had not yet affected the filtration
function of the kidneys and that the present data reflect an early
stage of renal disease. Consistent with this, analysis of Periodic
acid-Schiff (PAS) stained renal cross-sections by light microscopy
showed no overt renal abnormalities in all groups, except for a
mild glomerular hypercellularity in mice that had been exposed to
cholesterol chronically (HC and MC) (Figure S3).
Discussion
In this study, we used a well documented, humanized mouse
model of atherosclerosis, the ApoE*3Leiden mouse, to provide
evidence that alternating high cholesterol (HC) -cholesterol-free
(CON) diet can effectively diminish cardiovascular risk factors as
compared with daily HC diet. The alternating feeding regimen
reproduced most of the beneficial effects of daily cholesterol-free
diet, including strongly diminished occurrence of hepatic, vascular
and renal activation and inflammation. Furthermore, atheroscle-
rosis in the ALT group was reduced by half compared to that in
Table 2. Renal mRNA expression.
CON (n=15) HC (n=13) ALT (n=13) MC (n=14)
VCAM-1 1.0060.10
a 1.3960.14
b 1.0260.07
a 1.1060.11
ab
ICAM-1 1.0060.06
a 1.5160.20
b 0.9160.07
a 1.0560.07
a
E-selectin 1.0060.18
a 1.8560.27
b 1.2360.15
a 1.3960.16
ab
P-selectin 1.0060.11
a 1.6960.23
b 1.1460.14
ac 1.5760.21
bc
MCP-1 1.0060.11
ab 1.3360.15
a 0.8360.10
b 1.3260.15
a
CD68 1.0060.07
a 1.5360.10
b 1.0760.07
a 1.5160.10
b
Renal mRNA expression of endothelial activation related genes (VCAM-1, ICAM-
1, E-selectin, P-selectin) and inflammation related genes (MCP-1 and CD-68)
relative to expression of CON group. Groups are abbreviated as: control mice
fed a cholesterol-free Western type diet (CON); mice fed the same Western type
diet but supplemented with high dose (1% w/w) cholesterol (HC); mice with
alternate CON (4 days) and HC (3 days) diet regimen (ALT); mice fed Western
type diet supplemented with a medium dose (0.43% w/w) cholesterol (MC).
Data are expressed as means 6 SEM. Values in the same row with different
superscript letters are significantly different. P,0.05.
doi:10.1371/journal.pone.0018432.t002
Figure 4. Immunohistochemistry of VCAM-1 in the kidney. A) Expression and localization of VCAM-1 in renal sections of each group. Insert
shows a 2006magnification of a representative glomerulus which indicated by arrow. Control mice fed a cholesterol-free Western type diet (CON);
high dose (1% w/w) cholesterol diet (HC); alternate CON (4 days) and HC (3 days) diet regimen (ALT); medium dose (0.43% w/w) cholesterol diet (MC).
doi:10.1371/journal.pone.0018432.g004
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demonstrating that the concept of dietary manipulation is not
restricted to caloric restriction but is also applicable to alternating
dietary composition, our findings further underline the potential
efficacy of the concept of alternate diet regimens. The perception
that alternate cholesterol-free feeding (this paper) and alternate-
Figure 5. Immunohistochemistry for macrophages (CD68) in the kidney. A) Expression and localization of macrophages in renal sections.
Inset shows a 2006magnification of a representative glomerulus which indicated by arrow. B) Renal accumulation of macrophages was quantified by
morphometry. Data are expressed as a percentage of positive area occupied by FA-11 stained macrophages. Control mice fed a cholesterol-free
Western type diet (CON, n=15); high dose (1% w/w) cholesterol diet (HC, n=13); alternate CON (4 days) and HC (3 days) diet regimen (ALT, n=13);
medium dose (0.43% w/w) cholesterol diet (MC, n=14). Values are presented as means 6 SEM. ** P,0.01, *** P,0.001.
doi:10.1371/journal.pone.0018432.g005
Beneficial Effects of Alternate Dietary Regimen
PLoS ONE | www.plosone.org 7 March 2011 | Volume 6 | Issue 3 | e18432day fasting [14;15] are almost as effective as daily cholesterol-free
diet or daily caloric restriction respectively is of great societal
importance. It may be anticipated namely that alternating-diet
regimens may allow better compliance than would daily healthy
diet regimens.
Although the efficacy of the alternate concept is intriguing, the
exact molecular mechanisms underlying its favorable effects remain
to be established and are an attractive area for further investigation.
Some clues regarding the alternate HC diet might come from a
previous study that we performed on the effects of dietary cholesterol
on cardiovascular risk in ApoE3Leiden mice [16]. We showed that
with increasing dietary cholesterol intake, plasma cholesterol levels
increase and the liver switches from a resilient, adaptive state to an
inflammatory, pro-atherosclerotic state, which is associated with an
increase in endothelial dysfunction markers and early atherosclerotic
lesion formation. For example, liver-derived inflammation markers
such as serum amyloid A (SAA) and vascular activation markers such
as soluble E-selectin, VCAM, and von Willebrand factor increase
rapidly (within days) after consumption of a HC diet, and thus by far
precede the onset of early aortic lesion formation. In the present
study, the effects of alternating HC-CON diet were close to daily
CON diet and much more favorable compared to daily 0.43% (w/w)
cholesterol intake, despite an equal overall dietary cholesterol intake
for the two groups. The elevated hepatic free cholesterol and NF-kB
activity observed after feeding daily 1% or 0.43% dietary cholesterol
(HC and MC), was not seen in the ALT or CON groups.
Similarly, we observed protective effects of ALT diet on the
renal microvasculature. Endothelial adhesion molecules, including
E-selectin, P-selectin, VCAM-1 and ICAM-1 were significantly
upregulated in the HC group and moderately expressed in the MC
group. In contrast, these diet-induced renal effects were markedly
diminished in the ALT group displaying similar levels of
expression as CON. Moreover, enhanced expression of MCP-1
in conjunction with significant renal macrophage infiltrates,
particularly in the glomeruli, was observed in the HC and MC
groups but was absent in the ALT group. These observations are
in line with previous studies employing calorie restriction diets
showing significant reductions in glomerular VCAM expression
[17], renal monocyte/macrophage infiltration, mesangial expan-
sion [18], and development of proteinuria [19].
Our results suggest that the daily dietary cholesterol intake of
the HC and MC groups overcharges both hepatic and renal
resilience, which results in a metabolic overload. This induces
metabolic stress and inflammation [20] that equally affects both
the macro (atherosclerosis) and microvasculature (liver and
kidney). The ALT diet apparently provides these organs (liver
and kidney) with a certain degree of elasticity which allows the
mice to recover -during the cholesterol-free periods- from the
intermittent periods of HC feeding, and thus to cope with
alternating cholesterol stress.
Together, our own findings as well as the still nascent literature
suggest that the principle of alternating dietary regimens can
effectively modulate metabolic and functional risk factors. This
approach would be a potentially attractive strategy to be tested for
implementing more broadly in humans. If successful, it could
provide a novel and more acceptable strategy to protect against
the adverse effects of an unhealthy diet typical for the nutritional
milieu which modern humans have created for themselves and as
such could contribute to improve metabolic health. More work
needs to be done to fully establish the concept and to address some
of the outstanding questions. It needs to be ascertained whether
the concept can also be extended to other alternating-diet
regimens, including alternating saturated/unsaturated fat, alter-
nating high/low-fat or alternating high/low-carbohydrate. An
important issue also is whether the beneficial effects are valid both
for disease prevention and delaying and/or improving existing
metabolic diseases.
Supporting Information
Figure S1 Schematic illustration of feeding regimens.
Illustration of the feeding regimens during the experimental
period. The red droplets indicate blood sampling time points.
Experimental groups include from top to bottom; Control
mice fed a cholesterol-free Western type diet (CON); high dose
(1% w/w) cholesterol diet (HC); alternate CON (4 days) and HC
(3 days) diet regimen (ALT); medium dose (0.43% w/w)
cholesterol diet (MC).
(TIF)
Figure S2 Representative photomicrographs of aortic
root. Photomicrographs after histological staining with hematox-
ylin-phloxine-saffron. Control mice fed a cholesterol-free Western
type diet (CON); high dose (1% w/w) cholesterol diet (HC);
alternate CON (4 days) and HC (3 days) diet regimen (ALT);
medium dose (0.43% w/w) cholesterol diet (MC).
(TIF)
Figure S3 Representative photomicrographs of kidney
morphology. Photomicrographs after histological PAS staining.
Control mice fed a cholesterol-free Western type diet (CON); high
dose (1% w/w) cholesterol diet (HC); alternate CON (4 days) and
HC (3 days) diet regimen (ALT); medium dose (0.43% w/w)
cholesterol diet (MC).
(TIF)
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